Xylem Inc. (NYSE:XYL) Shares Sold by Penn Davis Mcfarland Inc.

Penn Davis Mcfarland Inc. trimmed its holdings in shares of Xylem Inc. (NYSE:XYLFree Report) by 0.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 96,804 shares of the industrial products company’s stock after selling 115 shares during the quarter. Xylem accounts for approximately 1.4% of Penn Davis Mcfarland Inc.’s portfolio, making the stock its 23rd biggest position. Penn Davis Mcfarland Inc.’s holdings in Xylem were worth $11,564,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Sava Infond d.o.o. increased its position in shares of Xylem by 164.3% during the 1st quarter. Sava Infond d.o.o. now owns 3,700 shares of the industrial products company’s stock worth $442,000 after purchasing an additional 2,300 shares during the last quarter. Keudell Morrison Wealth Management acquired a new stake in shares of Xylem during the 1st quarter worth about $220,000. Asset Management One Co. Ltd. increased its position in shares of Xylem by 5.1% during the 1st quarter. Asset Management One Co. Ltd. now owns 163,059 shares of the industrial products company’s stock worth $19,479,000 after purchasing an additional 7,978 shares during the last quarter. Figure 8 Investment Strategies LLC increased its position in shares of Xylem by 3.0% during the 1st quarter. Figure 8 Investment Strategies LLC now owns 20,663 shares of the industrial products company’s stock worth $2,468,000 after purchasing an additional 595 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. increased its position in shares of Xylem by 10.1% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 95,850 shares of the industrial products company’s stock worth $11,450,000 after purchasing an additional 8,832 shares during the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Stock Performance

Shares of XYL opened at $127.29 on Wednesday. The stock has a 50-day simple moving average of $122.93 and a 200-day simple moving average of $121.68. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.41 and a current ratio of 1.89. The stock has a market capitalization of $30.97 billion, a PE ratio of 34.22, a PEG ratio of 2.29 and a beta of 1.13. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $143.50.

Xylem (NYSE:XYLGet Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The industrial products company reported $1.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.08. The business had revenue of $2.07 billion during the quarter, compared to analysts’ expectations of $2.04 billion. Xylem had a return on equity of 10.12% and a net margin of 10.54%. The business’s quarterly revenue was up 1.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.90 EPS. On average, analysts predict that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Stockholders of record on Thursday, May 29th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.26%. The ex-dividend date is Thursday, May 29th. Xylem’s payout ratio is presently 43.01%.

Analyst Upgrades and Downgrades

XYL has been the subject of several research reports. Citigroup dropped their target price on Xylem from $152.00 to $134.00 and set a “buy” rating for the company in a research report on Monday, April 14th. JPMorgan Chase & Co. initiated coverage on Xylem in a research report on Friday, May 30th. They issued an “overweight” rating and a $148.00 target price for the company. Robert W. Baird dropped their target price on Xylem from $149.00 to $146.00 and set an “outperform” rating for the company in a research report on Wednesday, April 30th. Stifel Nicolaus lifted their target price on Xylem from $140.00 to $141.00 and gave the company a “buy” rating in a research report on Wednesday, April 30th. Finally, Raymond James Financial raised Xylem to a “hold” rating in a research report on Thursday, May 15th. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $143.71.

Check Out Our Latest Research Report on XYL

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Recommended Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.